Prospective, randomized, controlled trial of tranexamic acid in patients who undergo head and neck procedures.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 18503851.
- Also identified by DOI 10.1016/j.otohns.2008.02.022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine if tranexamic acid could reduce the drainage duration after head and neck procedures. Prospective, randomized, controlled trial. Patients who underwent head and neck operations were included. The study group was treated with tranexamic acid during the perioperative period whereas the control group received normal saline solution. Blood samples were also collected. The study and control groups consisted of 26 and 29 patients, respectively. Although there was a significant difference in the drainage amount between the two groups, (49.7 vs 88.8 mL, P = 0.041), no significant difference could be found in the drainage duration between the two groups (2.69 vs 3.07 days, P = 0.146). There was also no significant difference in the coagulation profiles between the two groups. We did not find a meaningful effect in reducing the drainage duration after head and neck procedures with the use of prophylactic tranexamic acid.
Medical subject headings
- Antifibrinolytic Agents
- Drainage
- Otorhinolaryngologic Surgical Procedures
- Postoperative Hemorrhage
- Thyroidectomy
- Tranexamic Acid